[Clinical effectiveness of nadroparin calcium in the surgical treatment of breast cancer].
The report deals with an assessment of frequency of fatal thromboembolic complications after surgery for breast cancer, in particular, frequency and severity of the side-effects of calcium nadroparin treatment as a component of surgical preparation. Considering the low incidence of thromboembolic complications in such patients and the side-effects of anti-coagulant therapy, it is suggested that decisions be made on a strictly individual basis under stringent clinical control.
Iaremchuk
A Ia
AIa
A.A. Bogomolets National Medical University, Municipal Oncological Hospital, Kiev, Ukraine.
Zotov
A S
AS
Cheshuk
V E
VE
Anikuc'ko
N F
NF
Zakhartseva
L M
LM
Diatel
M V
MV
Kravchenko
A V
AV
Lobanova
O E
OE
Sidorchuk
O I
OI
D000925:Anticoagulants / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000601:surgery*; D005260:Female; D006801:Humans; D008408:Mastectomy / Q000009:adverse effects*; D017762:Nadroparin / Q000627:therapeutic use*; D012189:Retrospective Studies; D013923:Thromboembolism / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D016896:Treatment Outcome
D000925:Anticoagulants; D017762:Nadroparin